Avastin, in combination with intravenous 5âfluorouracil-based chemotherapy, is indicated for the firstâ or secondâtment of patients with metastatic colorectal cancer.
Avastin, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-tment of patients with metastatic colorectal cancer who have progressed on a first-tin-containing regimen.